RxDoctor Payments Data

Shivani Sharma, MD

Family Medicine · Highland, ILNPI 1508342189

Payments from drug & device makers

$1,041in general payments, 2019–2025

Across 55 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$224
  • Lilly USA, LLC$181
  • Idorsia Pharmaceuticals US Inc$95
  • Boehringer Ingelheim$58
  • Novo Nordisk$55
  • Collegium Pharmaceutical, Inc.$53
  • plus $375 from 15 others

What the payments were for

  • Food & beverage$1,00897%
  • Other$333%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,041 in reported general payments places this provider in the 70th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$7,986
Medicare patients
289
Services billed
692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide157$233,808
EliquisApixaban209$204,670
OzempicSemaglutide111$167,530
JardianceEmpagliflozin137$147,226
TrulicityDulaglutide83$143,232
FarxigaDapagliflozin Propanediol134$113,932
Tresiba Flextouch U-200Insulin Degludec45$39,689
XareltoRivaroxaban35$35,857
RybelsusSemaglutide14$31,460
Breo ElliptaFluticasone/Vilanterol55$23,296
MyrbetriqMirabegron28$22,372
RexultiBrexpiprazole12$20,749
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$14,637
SymbicortBudesonide/Formoterol Fumarate37$12,594
VascepaIcosapent Ethyl26$12,230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$181$377,041240 claims
PfizerEliquis$39$204,670209 claims
Novo NordiskOzempic, Rybelsus$55$198,990125 claims
Boehringer IngelheimJardiance$58$147,226137 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$14$141,162186 claims
AbbVieSynthroid$224$4,24347 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Highland

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →